CJC-1295 (no DAC) 10 MG

CJC-1295 (no DAC) is a synthetic peptide derivative structurally related to growth hormone-releasing hormone (GHRH). It has been developed as a stabilized analog without a Drug Affinity Complex (DAC) for research purposes and is primarily studied in laboratory settings for its potential effects on stimulating growth hormone release, metabolism, and peptide pharmacology. Preclinical studies have investigated CJC-1295 (no DAC) in relation to experimental models of endocrine regulation, muscle growth, and metabolic function.

Research involving CJC-1295 (no DAC) commonly explores:

• Its role in promoting pulsatile secretion of growth hormone and insulin-like growth factor 1 (IGF-1) in cellular and animal models.
• Possible contributions to anabolic processes, fat metabolism, and recovery in metabolic and endocrine research systems.
• Experimental evaluation of its pharmacokinetics and activity duration without the DAC modification.
• Its activity in studies of aging, tissue repair, and metabolic disorders, where its peptide structure and receptor affinity are key topics of interest.
CJC-1295 (no DAC) is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Modified GHRH analog, CJC-1295 without DAC
• Purity: ≥98%
• CAS Number: 863288-34-0
• Molecular Formula: C172H265N47O51
• Molecular Weight: Approximately 3047.0 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.